Prevalence of anticardiolipin antibodies in various thrombotic conditions: A hospital-based study

Journal of Association of Physicians of India

Volumn 51, Issue APR, 2003, Pages 359-362

  Chandrashekhara, S ^a   Kirthi, R ^a   Varghese, Joyce ^a  

^a M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; RETROSPECTIVE STUDY; VEIN THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 0038052297     PISSN: 00045772     EISSN: 00045772     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bick RL, Kaplan H. Syndromes of thrombosis and hypercoagulability. Med Clin N Am 1998;82:409-58.
2. Bick RL. Antiphospholipid thrombosis syndromes. I 2001;7:241-58.
3. Lockshin MD. Pregnancy loss and antiphospholipid antibodies. Lupus 1998;7 Suppl 2:86-89.
4. Alarcon-Segovia D, Deleze M, Oria CV. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a review of 500 consecutive cases. Medicine 1989;68:366-70.
5. Harris EN, Gharavi AE, Hughes GRV. Antiphospholipid syndrome. Clin Rheum Dis 1985;11:591-5.
6. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
7. Nagaraja D, Christopher R, Manjari T. Anticardiolipin antibodies in ischemic stroke in the young: Indian Experience. J Neurol Sci 1997;150:137-42.
8. Christopher R, Nagaraja D, Dixit NS, Narayanan CP. Anticardiolipin antibodies: a study in cerebral venous thrombosis. Acta Neurol Scand 1999;99:121-4.
9. Shrivastava A, Dwivedi S, Aggarwal A, Misra R. Anti-cardiolipin and anti-beta2 glycoprotein I antibodies in Indian patients with systemic lupus erythematosus: association with the presence of seizures. Lupus 2001;10:45-50.
10. Jones HW, Ireland R, Senaldi G, et al. Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus. Ann Rheum Dis 1991;50:173-5.
11. Saxena R, Mohanty S, Srivastava A, Chaudhry VP, Kotwal J. Pathogenic factors underlying juvenile deep vein thrombosis in Indians. Eur J Haematol 1999;63:26-8.
12. Ghosh K, Shetty S, Madkaikar M, et al. Venous thromboembolism in young patients from western India: a study. Clin Appl Thromb Hemost 2001;7:158-65.
13. de Godoy JM, de Godoy MF, Braile DM, Torres CA. Prevalence of anticardiolipin antibody in peripheral arterial thrombosis. Angiology 2000;51:473-7.
14. Tuhrim S, Rand JH, Xiao-Xuan W, et al. Elevated anticardiolipin antibody is a stroke risk factor in a multi-ethnic population independent of isotype or degree of positivity. Stroke 1999;30:1561-5.
15. Bick RL, Arun B, Frenkel EP. Antiphospholipid-thrombosis syndromes. Haemostasis 1999;29:100-10.
16. Galli M, Finazzi G, Duca F, Norbis F, Moia M. The G191® A mutation of factor V, but not the G20210® A mutation of factor II or the C677® T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants. Br J Haematol 2000;108:865-70.
17. Cucurall E, Gharavi AE, Diri E, Mendez E, Kapoor D, Espinoza LR. IgA anticardiolipin and anti-(2-glycoprotein I are the most prevalent isotypes in African American patients with SLE. Am J Med Sci 1999;318:55-60.
18. Petri M. Diagnosis of antiphospholipid antibodies. Rheum Dis Clin North Am 1994;20:443-69.
19. Weidmann CE, Wallace DJ, Peter JB, et al. Studies of IgG, IgM and IgA antiphospholipid antibody isotopes in systemic lupus erythematosus. J Rheumatol 1988;15:74-9.
20. Dawn R, Sheppard DO. Activated protein C resistance: The most common risk factor for venous thromboembolism. J Am Board Fam Pract 2000;13:111-5.
21. Bick RL, Haas SK. International consensus recommendations. Summary statement and additional suggested guidelines. European Consensus Conference, November 1991. American College of Chest Physicians consensus statement of 1995. International Consensus Statement, 1997. Med Clin North Am 1998;82:613-33.